Why there’s no Ebola vaccine, yet?

Search for vaccine is often a very expensive business. There has to be a large ready market for pharmaceutical companies to invest their private capital. So, the question is, are drug companies interested in something that infects a “handful” of people each year somewhere in some poor countries? Ebola in US, well that’s something else. The first US Ebola case, Thomas Eric Duncan, is in serious condition in Dallas and could die. There is an experimental drug ZMapp used on several international aid workers and medical staff, but he didn’t get it because the company that makes ZMapp, Mapp Biopharmaceutical, has run out of supplies. …Or to simplify this issue, no funds – no drugs. Apparently, a better source of funding would save lives of ones who contracted Ebola. However, there are several smaller pharmaceuticals companies working on a treatment, but non of them started testing experimental drugs in-vivo. “Pharmaceutical companies can spend millions in developing...